Search research articles
Contact Us
Filters
Showing results (301-310 of 323) with videos related to
Page
of 33
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 16, 2026
Correction: Targeted Therapy of TERT-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy
Jingwei Chen, Christopher Nelson, Matthew Wong, et al.
Science Translational Medicine
|
November 6, 2015
Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastoma
Daniel R Carter, Jayne Murray, Belamy B Cheung, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 13, 2020
Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma
Lucas Moreno, Giuseppe Barone, Steven G DuBois, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 14, 2020
Targeted Therapy of <i>TERT</i>-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy
Jingwei Chen, Christopher Nelson, Matthew Wong, et al.
Molecular Cell
|
August 15, 2025
PRDX6 contributes to selenocysteine metabolism and ferroptosis resistance
Zhiyi Chen, Alex Inague, Kamini Kaushal, et al.
Science Advances
|
July 20, 2022
RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition
Carolina Nunes, Lisa Depestel, Liselot Mus, et al.
Molecular Cell
|
November 15, 2024
PRDX6 contributes to selenocysteine metabolism and ferroptosis resistance
Zhiyi Chen, Alex Inague, Kamini Kaushal, et al.
Science (New York, N.Y.)
|
December 8, 2018
A mechanistic classification of clinical phenotypes in neuroblastoma
Sandra Ackermann, Maria Cartolano, Barbara Hero, et al.
Biorxiv : the Preprint Server for Biology
|
May 5, 2025
Oncogene Silencing via ecDNA Micronucleation
Lotte Brückner, Robin Xu, Jun Tang, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
February 7, 2012
Diagnostics of autoimmune bullous diseases in German dermatology departments
Nina van Beek, Diana Knuth-Rehr, Peter Altmeyer, et al.
Page
of 33
Search research articles
Search
Showing results (301-310 of 323) with videos related to
Sort By:
Page
of 33
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 16, 2026
Correction: Targeted Therapy of TERT-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy
Jingwei Chen, Christopher Nelson, Matthew Wong, et al.
Science Translational Medicine
|
November 6, 2015
Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastoma
Daniel R Carter, Jayne Murray, Belamy B Cheung, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 13, 2020
Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma
Lucas Moreno, Giuseppe Barone, Steven G DuBois, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 14, 2020
Targeted Therapy of <i>TERT</i>-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy
Jingwei Chen, Christopher Nelson, Matthew Wong, et al.
Molecular Cell
|
August 15, 2025
PRDX6 contributes to selenocysteine metabolism and ferroptosis resistance
Zhiyi Chen, Alex Inague, Kamini Kaushal, et al.
Science Advances
|
July 20, 2022
RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition
Carolina Nunes, Lisa Depestel, Liselot Mus, et al.
Molecular Cell
|
November 15, 2024
PRDX6 contributes to selenocysteine metabolism and ferroptosis resistance
Zhiyi Chen, Alex Inague, Kamini Kaushal, et al.
Science (New York, N.Y.)
|
December 8, 2018
A mechanistic classification of clinical phenotypes in neuroblastoma
Sandra Ackermann, Maria Cartolano, Barbara Hero, et al.
Biorxiv : the Preprint Server for Biology
|
May 5, 2025
Oncogene Silencing via ecDNA Micronucleation
Lotte Brückner, Robin Xu, Jun Tang, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
February 7, 2012
Diagnostics of autoimmune bullous diseases in German dermatology departments
Nina van Beek, Diana Knuth-Rehr, Peter Altmeyer, et al.
Page
of 33